Jason B. Gibbons, PhD

home / authors / jason-gibbons-phd

Articles

April 2nd 2024

Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib

Jason B. Gibbons, PhD Charles L. Bennett, MD, PhD, MPP Kenneth R. Carson, MD Gerard F. Anderson, PhD

Ibrutinib has been selected for Medicare price negotiation under the Inflation Reduction Act. The authors summarize the House Oversight Committee investigation to be considered by CMS during the price negotiation process.

February 8th 2023

Humira: The First $20 Billion Drug

Jason B. Gibbons, PhD Micaela Laber, MPH, MBA Charles L. Bennett, MD, PhD, MPP

The authors review a House Oversight Committee investigation report on AbbVie’s practices pertaining to adalimumab (Humira) to shed light on broader pharmaceutical market dynamics hindering a competitive market.

March 11th 2022

Small Practice Participation and Performance in Medicare Accountable Care Organizations

Jason B. Gibbons, PhD Chiang-Hua Chang, PhD Mousumi Banerjee, PhD Jennifer Meddings, MD, MSc Edward C. Norton, PhD Lena Chen, MD, MS Julie P.W. Bynum, MD, MPH

Medicare beneficiaries attributed to small practices in accountable care organizations (ACOs) achieve greater savings than beneficiaries attributed to large practices in ACOs.